How are insulin doses calculated in adult patients with diabetes?

Insulin Dose Calculation in Adults with Diabetes

For adults with type 2 diabetes initiating basal insulin, start with 10 units per day OR 0.1-0.2 units/kg per day, then titrate by increasing 2 units every 3 days until fasting plasma glucose reaches goal without hypoglycemia. 1

Basal Insulin Initiation and Titration

Starting Dose

• Begin with 10 units daily OR 0.1-0.2 units/kg/day for basal analog or bedtime NPH insulin 1
• Set individualized fasting plasma glucose (FPG) goals based on patient characteristics 1

Titration Protocol

• Increase by 2 units every 3 days to reach FPG goal without hypoglycemia 1
• For hypoglycemia: determine the cause; if no clear reason exists, reduce dose by 10-20% 1
• Reassess adequacy at every visit, monitoring for signs of overbasalization (elevated bedtime-to-morning differential, hypoglycemia, high glucose variability) 1

Important Consideration

Always prescribe glucagon for emergent hypoglycemia when initiating insulin therapy 1

Adding Prandial Insulin (When A1C Remains Above Goal)

Initial Prandial Insulin Dose

• Start with 4 units per day OR 10% of basal insulin dose 1
• Administer with the largest meal or meal with greatest postprandial glucose excursion 1

Prandial Insulin Titration

• Increase by 1-2 units OR 10-15% of current dose based on glucose response 1
• For hypoglycemia: determine cause; if unclear, reduce corresponding dose by 10-20% 1

Advanced Insulin Regimens

Twice-Daily NPH Conversion

When converting from bedtime NPH to twice-daily regimen:

• Total NPH dose = 80% of current bedtime NPH dose 1
• Give 2/3 before breakfast, 1/3 before dinner 1
• Add 4 units of short/rapid-acting insulin to each injection OR 10% of reduced NPH dose 1

Full Basal-Bolus Regimen

For patients progressing to complete insulin replacement:

• If A1C <8% (<64 mmol/mol), consider lowering basal dose by 4 units per day or 10% of basal dose when adding prandial insulin 1
• Titrate each component based on individualized glucose patterns 1

Type 1 Diabetes Specific Calculations

Total Daily Dose (TDD) Estimation

• Typical starting dose: 0.5 units/kg/day in metabolically stable adults with type 1 diabetes 1
• Range: 0.4-1.0 units/kg/day depending on clinical factors 1
• Lower doses (0.2-0.6 units/kg) may be appropriate in young children or those with continued endogenous insulin production 1

Basal-Bolus Distribution

• Approximately 30-50% of TDD as basal insulin (recent evidence suggests closer to 30%) 1, 2
• Remainder as prandial insulin distributed across meals 1

Carbohydrate-to-Insulin Ratio (CIR)

Research suggests the traditional "500 rule" underestimates bolus needs:

• CIR = 300/TDD for breakfast 2
• CIR = 400/TDD for lunch and dinner 2
• Alternative formulas from pump studies: CIR = 300/TDD (general) 3

Correction Factor (CF)

• CF = 1500/TDD (more accurate than traditional 1800 rule) 3, 4
• This represents the expected glucose drop (mg/dL) per 1 unit of insulin 3

Mathematical Relationship

The relationship between dosing factors can be expressed as:

• 100/TBD = ICR = CF/4.5 3, 4
• Where TBD (total basal dose) = 0.2 × weight (kg) OR 0.4 × TDD 3, 4

Critical Clinical Pitfalls

When to Use Insulin as First Injectable

Consider insulin as the first injectable therapy when: 1

• Symptoms of hyperglycemia are present
• A1C >10% (>86 mmol/mol)
• Blood glucose ≥300 mg/dL (≥16.7 mmol/L)
• Type 1 diabetes is a diagnostic possibility

Avoiding Therapeutic Inertia

• Reassess and modify insulin doses regularly every 3-6 months 1
• Do not delay intensification when A1C remains above goal despite adequate basal insulin titration 1

Combination Therapy Considerations

• If A1C remains above goal on basal insulin and patient is not on GLP-1 RA or dual GIP/GLP-1 RA, consider adding these agents in combination with insulin (fixed-ratio products like IDegLira or iGlarLixi may be appropriate) 1

Special Populations

Patients with Renal Impairment

• Lower starting dose (0.114 U/kg/day for glargine) in patients with eGFR <60 mL/min/1.73 m² 5

Patients with Retinopathy

• Reduced starting dose (0.120 U/kg/day for glargine) may be appropriate 5

Women and Patients on Sulfonylureas

• Slightly decreased starting doses (0.135 U/kg/day for women, 0.132 U/kg/day with sulfonylureas) may reduce hypoglycemia risk 5